We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRNY:NASDAQKearny Financial Analysis

Data as of 2026-07-27 - not real-time

$9.44

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kearny Financial is trading just above its short‑term moving average while the medium‑term average remains lower, a classic bullish signal despite a bearish MACD histogram. The relative strength index sits comfortably in the middle of its range, suggesting neither overbought nor oversold conditions, and price action is hovering near a well‑tested support level with upside potential that analysts estimate in the low double‑digit range. Volume has been tapering, yet the stock’s beta is modest, indicating limited market‑wide turbulence, and the 30‑day volatility reading is notably high, reflecting recent price swings. Valuation metrics are attractive: the price‑to‑earnings multiple is below the industry average and the price‑to‑book ratio is under one, while the dividend yield is among the higher peers, making the stock appealing for income‑focused investors.
The fundamentals show solid revenue growth and healthy operating margins, but cash generation is constrained and debt levels are sizable relative to cash on hand, raising questions about dividend sustainability. Regulatory and credit risks inherent to regional banks add a layer of caution, but the company’s strong capital position and consistent earnings support a positive outlook. Overall, the blend of technical momentum, undervalued pricing, and generous yield positions KRNY as a compelling buy for investors comfortable with moderate risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • bullish moving‑average crossover
  • high dividend yield
  • undervalued relative valuation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • sustained revenue growth
  • strong operating margins
  • attractive price‑to‑book ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • stable earnings profile
  • potential for dividend growth
  • positioning within a low‑beta, income‑oriented niche

Key Metrics & Analysis

Financial Health

Revenue Growth14.90%
Profit Margin20.56%
P/E Ratio16.6
ROE4.79%
ROA0.47%
P/B Ratio0.8
Industry P/E18.0

Technical Analysis

TrendBullish
RSI56.5
Support$8.75
Resistance$9.76
MA 20$9.40
MA 50$8.77
MA 200$7.78
MACDBearish
VolumeDecreasing
Fear & Greed Index86.66

Valuation

Target Price$10.50
Upside/Downside11.29%
GradeUndervalued
TypeBlend
Dividend Yield4.69%

Risk Assessment

Beta0.61
Volatility28.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.